TRex Bio Inc., an early-stage biotech company focused on autoimmune and inflammatory diseases, raised $116.7 million in a US initial public offering that priced at the bottom of its marketed range.

Bellevue-based wellness company Viome has acquired Solaria Bio, a wellness company headquartered in the Boston area. With the ...

An NZX-listed company is set to import and distribute pharmaceutical-grade MDMA, better known as a party drug, for treatment in therapy.

Rua Bioscience Limited (NZX: RUA) ('Rua”) and PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTCQB: MDXXF) ('PharmAla”) announce that Rua and PharmAla Biotech Inc., a subsidiary of PharmAla, have signed ...

Former SEC enforcer Rebecca Fike warns the new SEC-FDA information-sharing deal will likely trigger more insider trading ...

VivoSim is a San Diego biotech company whose goal is to limit the impact of failure in human trials. By using lab-grown human ...

Obatala Sciences, a New Orleans-based biotechnology company, is establishing its first East Coast operation in Charleston ...

Founded in 2019 as Entos, Iambic is advancing a pipeline of drug candidates developed using its AI platform to treat solid ...

Island Pharmaceuticals has issued 500,000 unquoted options under its employee incentive scheme, expiring on various dates and at various exercise prices. The options are subject to transfer ...

Linical Co., Ltd. ( ($JP:2183) ) has issued an update. Linical Co., Ltd. has secured a large new order from a U.S. biotechnology company worth 20.4 million ...

First-in-human ER-100 data support dose escalation, with early visual-field signals in two of three glaucoma patients.

How has the NIH been spending its budget? And why are biotech investors feeling gloomy? Find out on this week's episode of ...